Financhill
Sell
42

FDMT Quote, Financials, Valuation and Earnings

Last price:
$10.70
Seasonality move :
3.13%
Day range:
$10.67 - $11.50
52-week range:
$2.24 - $12.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4,761.31x
P/B ratio:
1.66x
Volume:
485.7K
Avg. volume:
956.7K
1-year change:
56.89%
Market cap:
$611.3M
Revenue:
$37K
EPS (TTM):
-$3.94

Earnings Data

Next earnings date for FDMT
Feb 27
2026
Most recent earnings per share
-$1.01
Missed by $0.03
(Nov 10/2025)
Consensus Estimate
-$0.98
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

FDMT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/27/2026 Q4 $29.7M -- -- -$0.53 --
11/10/2025 Q3 $403K $90K -$1.01 -$0.98 -$0.03
08/11/2025 Q2 $522.8K $15K -$0.98 -$0.69 -$0.28
05/08/2025 Q1 $446.3K $14K -$0.86 -$0.86 $0.00
02/28/2025 Q4 $2.3M $1K -$1.08 -$0.84 -$0.25
11/13/2024 Q3 $601.1K $3K -$0.79 -$0.70 -$0.08
08/08/2024 Q2 $685.7K $5K -$0.63 -$0.71 $0.08
05/09/2024 Q1 $915.7K $28K -$0.66 -$0.76 $0.10
02/29/2024 Q4 $2.4M -- -- -$0.73 --
11/09/2023 Q3 -- $20.2M -$0.24 -- --
08/09/2023 Q2 -- $239K -$0.77 -- --
05/10/2023 Q1 -- $298K -$0.88 -- --
03/15/2023 Q4 -- $1.2M -$0.84 -- --
11/08/2022 Q3 -- $500K -$0.79 -- --
08/11/2022 Q2 -- $162K -$0.87 -- --
05/12/2022 Q1 -- $1.2M -$0.82 -- --
03/28/2022 Q4 -- $92K -$0.85 -- --
11/10/2021 Q3 -- $1.4M -$0.82 -- --
08/12/2021 Q2 -- $14.6M -$0.28 -- --
05/13/2021 Q1 -- $2M -$0.61 -- --
03/25/2021 Q4 -- -- -$0.77 -$0.66 -$0.11
09/30/2020 Q3 -- $7.4M -$0.29 -- --
06/30/2020 Q2 -- $3.6M -$0.57 -- --
03/31/2020 Q1 -- $3.5M -$0.50 -- --
12/31/2019 Q4 -- $2M -$0.61 -- --
09/30/2019 Q3 -- $540K -$0.63 -- --

4D Molecular Therapeutics, Inc. Earnings Questions

  • How Much did 4D Molecular Therapeutics, Inc. Generate in Revenue Last Quarter?

    4D Molecular Therapeutics, Inc. reported $90K worth of top line sales in its most recent quarter.

  • Did 4D Molecular Therapeutics, Inc. Beat Earnings Last Quarter?

    4D Molecular Therapeutics, Inc. announced earnings per share of -$1.01 which represents a miss of analyst forecast a -$0.98 per share.

  • Is 4D Molecular Therapeutics, Inc. Profitable?

    4D Molecular Therapeutics, Inc. reported -$1.9M that represents -$0.03 per share over the last quarter.

  • What is the Analyst Consensus for 4D Molecular Therapeutics, Inc. EPS Next Year?

    4D Molecular Therapeutics, Inc.'s earnings are forecast to decrease from -$2.98 per share to -$2.92 per share next year representing a decrease of -9.27%.

  • When is 4D Molecular Therapeutics, Inc.'s Earnings Date?

    4D Molecular Therapeutics, Inc.'s next earnings date is February 27, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock